These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 18089780)

  • 41. Q2ChIP, a quick and quantitative chromatin immunoprecipitation assay, unravels epigenetic dynamics of developmentally regulated genes in human carcinoma cells.
    Dahl JA; Collas P
    Stem Cells; 2007 Apr; 25(4):1037-46. PubMed ID: 17272500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Loss of p16INK4 expression by methylation is associated with lifespan extension of human mammary epithelial cells.
    Huschtscha LI; Noble JR; Neumann AA; Moy EL; Barry P; Melki JR; Clark SJ; Reddel RR
    Cancer Res; 1998 Aug; 58(16):3508-12. PubMed ID: 9721850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA methylation control of tissue polarity and cellular differentiation in the mammary epithelium.
    Plachot C; Lelièvre SA
    Exp Cell Res; 2004 Aug; 298(1):122-32. PubMed ID: 15242767
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
    Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
    J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
    Labelle M; Schnittler HJ; Aust DE; Friedrich K; Baretton G; Vestweber D; Breier G
    Cancer Res; 2008 Mar; 68(5):1388-97. PubMed ID: 18316602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aging: gene silencing or gene activation?
    Burzynski SR
    Med Hypotheses; 2005; 64(1):201-8. PubMed ID: 15533642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thyroid transcription factor-1 inhibits transforming growth factor-beta-mediated epithelial-to-mesenchymal transition in lung adenocarcinoma cells.
    Saito RA; Watabe T; Horiguchi K; Kohyama T; Saitoh M; Nagase T; Miyazono K
    Cancer Res; 2009 Apr; 69(7):2783-91. PubMed ID: 19293183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chromatin structure regulation in transforming growth factor-beta-directed epithelial-mesenchymal transition.
    Blumenberg M; Gao S; Dickman K; Grollman AP; Bottinger EP; Zavadil J
    Cells Tissues Organs; 2007; 185(1-3):162-74. PubMed ID: 17587822
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel functional polymorphism in the transforming growth factor-beta2 gene promoter and tumor progression in breast cancer.
    Beisner J; Buck MB; Fritz P; Dippon J; Schwab M; Brauch H; Zugmaier G; Pfizenmaier K; Knabbe C
    Cancer Res; 2006 Aug; 66(15):7554-61. PubMed ID: 16885354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band.
    Frigola J; Song J; Stirzaker C; Hinshelwood RA; Peinado MA; Clark SJ
    Nat Genet; 2006 May; 38(5):540-9. PubMed ID: 16642018
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RAS and TGF-beta exert antagonistic effects on extracellular matrix gene expression and fibroblast transformation.
    Wisdom R; Huynh L; Hsia D; Kim S
    Oncogene; 2005 Oct; 24(47):7043-54. PubMed ID: 16007133
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone marrow stroma influences transforming growth factor-beta production in breast cancer cells to regulate c-myc activation of the preprotachykinin-I gene in breast cancer cells.
    Oh HS; Moharita A; Potian JG; Whitehead IP; Livingston JC; Castro TA; Patel PS; Rameshwar P
    Cancer Res; 2004 Sep; 64(17):6327-36. PubMed ID: 15342422
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targets of genome copy number reduction in primary breast cancers identified by integrative genomics.
    Chen W; Salto-Tellez M; Palanisamy N; Ganesan K; Hou Q; Tan LK; Sii LH; Ito K; Tan B; Wu J; Tay A; Tan KC; Ang E; Tan BK; Tan PH; Ito Y; Tan P
    Genes Chromosomes Cancer; 2007 Mar; 46(3):288-301. PubMed ID: 17171680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Basement membrane component laminin-5 is a target of the tumor suppressor Smad4.
    Zapatka M; Zboralski D; Radacz Y; Böckmann M; Arnold C; Schöneck A; Hoppe S; Tannapfel A; Schmiegel W; Simon-Assmann P; Schwarte-Waldhoff I
    Oncogene; 2007 Mar; 26(10):1417-27. PubMed ID: 16953227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pancreatic carcinoma cell lines with SMAD4 inactivation show distinct expression responses to TGFB1.
    Jonson T; Heidenblad M; Håkansson P; Gorunova L; Johansson B; Fioretos T; Höglund M
    Genes Chromosomes Cancer; 2003 Apr; 36(4):340-52. PubMed ID: 12619158
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histone deacetylase 4 mediates SMAD family member 4 deacetylation and induces 5-fluorouracil resistance in breast cancer cells.
    Yu SL; Lee DC; Son JW; Park CG; Lee HY; Kang J
    Oncol Rep; 2013 Sep; 30(3):1293-300. PubMed ID: 23817620
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells.
    Gudas JM; Li T; Nguyen H; Jensen D; Rauscher FJ; Cowan KH
    Cell Growth Differ; 1996 Jun; 7(6):717-23. PubMed ID: 8780885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential and epigenetic gene expression profiling identifies frequent disruption of the RELN pathway in pancreatic cancers.
    Sato N; Fukushima N; Chang R; Matsubayashi H; Goggins M
    Gastroenterology; 2006 Feb; 130(2):548-65. PubMed ID: 16472607
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Silencing of the mammary-derived growth inhibitor (MDGI) gene in breast neoplasms is associated with epigenetic changes.
    Huynh H; Alpert L; Pollak M
    Cancer Res; 1996 Nov; 56(21):4865-70. PubMed ID: 8895735
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma.
    Vibhakar R; Foltz G; Yoon JG; Field L; Lee H; Ryu GY; Pierson J; Davidson B; Madan A
    Neuro Oncol; 2007 Apr; 9(2):135-44. PubMed ID: 17329407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.